Fig. 1From: Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitisTSH and Free T4 levels after starting nivolumab therapy. Nivolumab started at time 0. Vertical arrow indicates the time at which combined immune checkpoint inhibitor (ICI) therapy with nivolumab and ipilimumab was started. TSH normal range: 0.34–5.6 μIU/mL, free T4 normal range 0.8–1.5 ng/dLBack to article page